Malignant Uveal Neoplasm — Trials

Malignant Uveal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 59
Recruiting: 29
Ph III recruiting: 6
Growth YoY: —
Industry share: 36%
Top sponsor: IDEAYA Biosciences
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (34)

clinicaltrialsPublishedShowing 1–17 of 17 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05524935	Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma	active not recruiting	Phase 2	12	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Sep 15, 2026	clinicaltrials
NCT01979523	Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma	active not recruiting	Phase 2	42	National Cancer Institute (NCI)NIH	3	Aug 6, 2026	clinicaltrials